These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8172)

  • 21. Corneal and skin changes in tyrosinaemia.
    Billson FA; Danks D
    Br J Ophthalmol; 1976 Aug; 60(8):600. PubMed ID: 974062
    [No Abstract]   [Full Text] [Related]  

  • 22. [Type II oculo-cutaneous tyrosinosis or Richner-Hanhart syndrome--apropos of a case].
    Foels MO; Dufier JL; Renard G; Gounod N; D'Hermies F; Pouliquen Y
    Bull Soc Ophtalmol Fr; 1989 Jan; 89(1):21-4. PubMed ID: 2574638
    [No Abstract]   [Full Text] [Related]  

  • 23. [Transitory hypertyrosinemia of young infants and its relation to vitamin C].
    Henze H; Bremer HJ
    Monatsschr Kinderheilkd (1902); 1969 Jun; 117(6):433-6. PubMed ID: 4393253
    [No Abstract]   [Full Text] [Related]  

  • 24. [Presentation of a case of chronic type 1 tyrosinemia. Diet therapy and clinical outcome].
    Gabrielli O; Maiorana A; Paris D; Zanobini R; Renda B; Montali U; Coppa G
    Minerva Pediatr; 1978 Aug; 30(16):1329-34. PubMed ID: 692506
    [No Abstract]   [Full Text] [Related]  

  • 25. Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia.
    deGroot GW; Dakshinamurti K; Allan L; Haworth JC
    Pediatr Res; 1980 Jul; 14(7):896-8. PubMed ID: 6106182
    [No Abstract]   [Full Text] [Related]  

  • 26. [Sepsis, as the presenting form of hereditary tyrosinemia type I].
    Iglesias Niubo J; Riudor Taravilla E; Goma Brufau AR; Civit Colas MA; Suñé Gracia JM; Bertrán Sanges JM; Gallart Catalá A
    An Esp Pediatr; 1988 Sep; 29(3):235-8. PubMed ID: 3057981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful dietary control of tyrosinemia II.
    Machino H; Miki Y; Kawatsu T; Kida K; Matsuda H
    J Am Acad Dermatol; 1983 Oct; 9(4):533-9. PubMed ID: 6195199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hereditary tyrosinemia and alpha-1-fetoprotein. I. Clinical value of alpha-fetoprotein in hereditary tyrosinemia].
    Bélanger L; Bélanger M; Prive L; Larochelle J; Tremblay M; Aubin G
    Pathol Biol (Paris); 1973 May; 21(5):449-55. PubMed ID: 4125220
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient tyrosinemia of the newborn: dietary and clinical aspects.
    Avery ME; Clow CL; Menkes JH; Ramos A; Scriver CR; Stern L; Wasserman BP
    Pediatrics; 1967 Mar; 39(3):378-84. PubMed ID: 6018968
    [No Abstract]   [Full Text] [Related]  

  • 30. Tyrosinemia without liver or renal damage with plantar and palmar keratosis and keratitis (hypertyrosinemia type II).
    Pelet B; Antener I; Faggioni R; Spahr A; Gautier E
    Helv Paediatr Acta; 1979 May; 34(2):177-83. PubMed ID: 156708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal tyrosine crystals in transient neonatal tyrosinemia.
    Driscoll DJ; Jabs EW; Alcorn D; Maumenee IH; Brusilow SW; Valle D
    J Pediatr; 1988 Jul; 113(1 Pt 1):91-3. PubMed ID: 3385538
    [No Abstract]   [Full Text] [Related]  

  • 32. [Disorders in the tyrosine metabolism. II. Tyrosinemia - a congenital metabolic disorder].
    Vulović D; Hajduković R; Sindjić M; FilipovićD ; Dozić S
    Srp Arh Celok Lek; 1974 Jan; 102(1):9-20. PubMed ID: 4368107
    [No Abstract]   [Full Text] [Related]  

  • 33. A mouse model for human hereditary tyrosinemia I.
    Holdener BC; Magnuson T
    Bioessays; 1994 Feb; 16(2):85-7. PubMed ID: 8147847
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tyrosine metabolism and its relations to hypertyrosinemia states].
    Farriaux JP; Dhondt JL
    Pathol Biol (Paris); 1973 May; 21(5):531-43. PubMed ID: 4146868
    [No Abstract]   [Full Text] [Related]  

  • 35. The management of transient tyrosinemia of the newborn.
    Chase HP; O'Brien D
    Pediatrics; 1967 Aug; 40(2):308-9. PubMed ID: 5006599
    [No Abstract]   [Full Text] [Related]  

  • 36. [Tyrosinemia].
    Mrskos A; Pospísil R; Podhradská O; Saxl O
    Cesk Pediatr; 1970 Mar; 25(3):109-11. PubMed ID: 5440258
    [No Abstract]   [Full Text] [Related]  

  • 37. [Renal involvement in type I tyrosinemia].
    Cochat P; Guibaud P; Baverel G
    Arch Pediatr; 1994 Apr; 1(4):417-8. PubMed ID: 7842099
    [No Abstract]   [Full Text] [Related]  

  • 38. Genetic aspects of tyrosinemia.
    Dallaire L
    Can Med Assoc J; 1967 Oct; 97(18):1098-9. PubMed ID: 6050913
    [No Abstract]   [Full Text] [Related]  

  • 39. [Transient tyrosinemia in a premature infant].
    Hertel J
    Ugeskr Laeger; 1980 May; 142(20):1286-7. PubMed ID: 7404719
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical picture and problems of keratoplasty in Richner-Hanhart syndrome (tyrosinemia type II).
    Sayar RB; von Domarus D; Schäfer HJ; Beckenkamp G
    Ophthalmologica; 1988; 197(1):1-6. PubMed ID: 3054681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.